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Osteoarthritis (OA) is a degenerative disease of the articular cartilage, resulting in
pain and total joint disability. Recent studies focused on the role of the metabolic
syndrome in inducing or worsening joint damage suggest that chronic low-grade
systemic inflammation may represent a possible linking factor. This finding
supports the concept of a new phenotype of OA, a metabolic OA. The gut
microbiome is fundamental for human physiology and immune system
development, among the other important functions. Manipulation of the gut
microbiome is considered an important topic for the individual health in different
medical fields such as medical biology, nutrition, sports, preventive and
rehabilitative medicine. Since intestinal microbiota dysbiosis is strongly.e01134
vier Ltd. This is an open access article under the CC BY-NC-ND license
y-nc-nd/4.0/).
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is conceivable that also the pathogenesis of OA might be related to it. However, the
mechanisms and the contribution of intestinal microbiota metabolites in OA
pathogenesis are still not clear. The aim of this narrative review is to review
recent literature concerning the possible contribution of dysbiosis to OA onset
and to discuss the importance of gut microbiome homeostasis maintenance for
optimal general health preservation.
Keywords: Internal medicine, Metabolism, Nutrition, Pathology, Physiology,
Public health, Microbiology
1. Introduction
Osteoarthritis (OA), is a degenerative disease characterized by the progressive dete-
rioration of the articular cartilage, resulting in pain and total joint disability at
advanced stages. Disease progression can be dependent on genetic and epigenetic
factors, sex, ethnicity and age, and it is also associated with obesity, overweight, di-
etary factors, sedentary lifestyle, lubricin loss and sport injuries [1, 2, 3, 4, 5]. It is a
multifactorial disorder with a very complicated etiology, where the triggering factor
is still a “mystery”. Recent studies, confirming an association between type 2 dia-
betes, cardiovascular diseases, obesity and OA, have focused on the role of the meta-
bolic syndrome in inducing or exacerbating joint damage [6, 7]. There is some
evidence showing that the linking factor between metabolic abnormalities and the
OA onset could be represented by the persistence of a chronic low-grade systemic
inflammation [8]. These findings support the idea of a new phenotype of OA, a meta-
bolic OA, in addition to the age-related and injury-related phenotypes [9]. Intestinal
microbiota and its metabolic derivates are highly associated with various aspects of
the host physiology such as development, metabolism, immunity and longevity. Gut
microbiome dysbiosis has been associated with the pathogenesis of various diseases,
such as inflammatory bowel syndrome, obesity and cancer [10,11, 12] (Fig. 1).
Recently, the involvement of intestinal microbiota in autoimmune diseases such
as rheumatoid arthritis and celiac disease, has been also investigated [13, 14]. In
the last decade some authors have also tried to explain the involvement of gut micro-
biota or its metabolic products in the development of OA [15, 16]. Indeed, it is
conceivable that since dysbiosis of the intestinal microbiota is strongly associated
with the pathogenesis of several metabolic and inflammatory diseases, it may also
be linked to OA pathogenesis. However, the exact mechanism and the contribution
of intestinal microbiota metabolites to OA pathogenesis has still not being defined
and needs to be further explored. The aim of this narrative review is to review the
recent literature regarding the potential relationship of microbiome dysbiosis and
OA onset, and to discuss the importance of gut microbiome homeostasison.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Fig. 1. The figure represents the main factors involved in dysbiosis of the gut microbiome. The self-
antigen immune-activation by dysbiosis could lead to the development of different diseases such as can-
cer, Type I Diabetes, Rheumatoid Arthritis, Spondyloarthritis, Osteoarthritis, Autoimmune Hepatitis and
Multiple Sclerosis. This figure was drawn using the software CorelDraw and the vector image bank of
Servier Medical Art (http://smart.servier.com/). Servier Medical Art by Servier is licensed under a
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view is, surely, due both to the paucity of the studies in this field and to the conse-
quent lack of a systematic approach like PRISMA Statement or similar to provide a
more balanced view on the current state of knowledge in this research field.
Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).on.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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2.1. Microbiome in health and disease
For several years, the potential role played by the microbiome in health and disease
has remained unnoticed. With the advent of cutting-edge sequencing technologies
understanding the composition and functions of the microbiome has been made
possible. The human microbiota represents a collection of microorganisms living
on the surface and inside the host body [17]. More than a 100 trillion of prokaryotic
cells have been identified as having a role in supporting the biological functions of
the human body. At any given time, we carry 3e6 pounds of bacteria, containing
roughly 3 million protein-coding genes [18]. In the human body there are several
microbial niches that are in balance with a specific nutritional condition [19]. An
important role played by the gut microbiome, in particular, is maintaining the ho-
meostasis with the host [20]. The gut microbiome is fundamental for human phys-
iology, immune system development, digestion, fat storage, angiogenesis
regulation, behavior, development and detoxification reactions [21, 22]. Some of
the microorganisms of the gut microbiome encode proteins, such as enzymes
required for the hydrolysis of dietary compounds, otherwise indigestible, and the
synthesis of vitamins [23, 24]. The most abundant microbiota phyla living in the
healthy gut are Firmicutes, Bacteroidetes and Actinobacteria, while Proteobacteria,
Fusobacteria, Cyanobacteria and Verrucomicrobia are usually less present [25, 26].
The presence of methanogenic archaea (especiallyMethanobrevibacter smithii), Eu-
carya (predominantly yeasts), and multiple phages has also been reported [27].
However, the microbiome content varies enormously from one person to another
[26]. The microbiome is extremely dynamic and can be influenced by a number
of factors, such as age and travel [28], diet [29], hormonal cycles [30], therapies
and illness [31]. Moreover, variations in microbiome patterns have been identified
in different geographical locations, as demonstrated by He et al., [32]. In particular,
it was shown that, within the same geographical location, it is the different ethnicity
that can be accounted for the most to explain the interindividual dissimilarities in mi-
crobiome composition. In particular, three main poles, characterized by operational
taxonomic units (OTUs) have been classified as Prevotella (Moroccans, Turks, Gha-
naians), Bacteroides (African Surinamese, South-Asian Surinamese), and Clostri-
diales (Dutch) [33]. The colonization of the host body by the microbiome,
determines the presence of two phenotypes, one inherited from our parents and
the other acquired through the microbiome. The alteration of the gut microbiome
has the ability to dramatically influence health outcomes and its homeostasis may
be interrupted under certain pathological conditions. It has been shown that in genet-
ically susceptible individuals, environmental factors (e.g., diet, smoke and alcohol)
can disturb the gut microbial populations, causing dysregulations in host innate and
adaptive immune systems, leading to the development of several diseases [19]. Inon.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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system and the altered gut microbiome that affects the pathogenesis of several dis-
ease states such as cancer, metabolic syndrome, inflammatory bowel syndrome,
nonalcoholic fatty liver disease [12] and many autoimmune diseases, including auto-
immune hepatitis, type 1 diabetes, spondyloarthritis, multiple sclerosis and rheuma-
toid arthritis [34]. All these findings, along with the correlation between the
numerous risk factors shared by gut dysbiosis and OA such as aging, gender, obesity
and quality of nutrients intake, also suggested the possible involvement of intestine
microflora alterations in the pathogenesis of musculoskeletal disorders (Fig. 2).2.2. Links between gut microbiome alterations and osteoarthritis-
related risk factors
2.2.1. Aging
Different pathophysiological mechanisms, including thinning of cartilage, oxidative
damage, muscle weakening and a reduction in proprioception, have been proposed
to clarify the involvement of age in OA [35]. Several studies have demonstrated that,
older people also show significant difference in gut microbiome compared with
young people, such as greater proportion of Bacteroides, and distinct abundance
pattern of Clostridium groups [36, 37]. The variation within the gut microbiomeFig. 2. The etiology of osteoarthritis (OA) is still unknown. Various risk factors have been reported to
negatively influence OA onset including age, sex, obesity, immune activation and incorrect diet.
on.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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tion, metabolic alterations and organ disorders [38, 39]. It has been revealed that in
Drosophila the dysbiosis of intestinal microbiome greatly precedes and predicts age-
related intestinal barrier dysfunction [40]. Moreover, targeting of the aging-related
dysbiosis of intestinal microbiome improves these dysfunctions and maintains life-
span in Drosophila [40]. The variations in the gut microbiota with aging are
commonly linked with physiological alterations of the gastrointestinal tract, and
also, to variations in dietary patterns, all together leading to decline in cognitive
and immune functions and contributing to frailty [41]. With aging, the gut micro-
biota is characterized by a reduced bacterial diversity, variations in the dominant spe-
cies and decline in those beneficial ones [42]. More specifically, when comparing the
gut microbiota of elderly with that of younger subjects, lower levels of Firmicutes,
especially Clostridium cluster XIVa and Faecalibacterium prausnitzii, and Actino-
bacteria (mainly Bifidobacteria), and increased populations of Proteobacteria, are
found [43, 44]. Moreover, recent studies demonstrate that gut microbiota may pro-
mote frailty physiopathology by stimulating chronic inflammation insurgence and
anabolic resistance, suggesting its involvement in numerous others chronic
inflammation-based disorders [45].2.2.2. Gender
The prevalence and the severity of OA in hip, knee and hand are higher in women
than in men, and they even increase with menopause [35, 46, 47]. These findings
suggest that there are differences based on hormonal factors such as high estrogen
levels in women, that may determine differences in cartilage volume and bone/mus-
cle strength [48]. Gender effects on gut microbiome have been investigated in
several vertebrate species, such as fish, mice, and humans [49]. However, since
the inter-individual dissimilarities in microbiome composition are quite common,
more studies are needed to support the idea of the effective gender influence on
gut microbiome alterations.2.2.3. Obesity
Another well-known risk factor for OA is obesity [35]. The biological process by
which obesity promotes OA onset, is not completely understood. From the mechan-
ical point of view, the link between obesity and OA involves excessive joint loading
as a result of increased body weight. The latter, usually, leads to the physiologically
decreased movement, that finally results in a decreased release of synovial fluid into
the joint capsule and, thus, in the decreased tribology properties of the articular carti-
lage. From the molecular point of view, a more complex etiology for obesity-
induced OA has been reported, encompassing chronic low-grade inflammatory state,
mainly due to increased adipokine levels [50, 51]. It has been shown that intestinalon.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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ment of obesity. Obesity is associated with phylum-level changes in the microbiome
(Firmicutes/Bacteroidetes), reduced bacterial diversity, and altered representation of
bacterial genes and metabolic pathways [52]. In obese people, the ratio of Firmicutes
to Bacteroidetes is increased, which stimulates the production of biologically active
metabolites, such as short chain fatty acids (SCFAs) [53]. The formation of SCFAs is
the result of a complex interplay between diet and the gut microbiota within the gut
lumen environment. SCFAs represent the major carbon flux from the diet through
the gut microbiota to the host and evidence is emerging for a regulatory role of
SCFA in local, intermediate and peripheral metabolism [54]. Recent evidence sug-
gests that SCFAs may regulate directly or indirectly physiological and pathological
processes associated to obesity, energy regulation and metabolism. Indeed, increased
levels of SCFAs represent an additional energy source, and cause an imbalance in
energy regulation, leading to obesity onset. Simultaneously, SCFAs participate in
glucose-stimulated insulin secretion and release of peptide hormones which control
appetite. This apparent contradictory situation may indicate the involvement of addi-
tional bacteria or their metabolites that may trigger regulatory cascades and alter the
general metabolic homeostasis [55]. Since there is some degree of correlation be-
tween dysbiosis of the gut microbiome and obesity, it is conceivable that the former
may also be linked to other obesity-related conditions characterized by low grade
chronic inflammation, including OA. OA is a low-grade inflammatory condition,
and the high levels of lipopolysaccharides seen in obese people and in those affected
by metabolic syndrome, may contribute to its onset. Lipopolysaccharides could be
considered a major hidden risk factor that provides a unifying mechanism to explain
the association between obesity, metabolic syndrome and OA [56]. However, this
association also warrants further investigations.2.2.4. Dietary factors
Several dietary factors, along with quality and quantity of nutrients intake, have been
reported to be involved in pathogenesis of OA. Among these, vitamins, fatty acids
and magnesium seem to play a key role [57, 58]. It has been shown that low intake of
vitamin D and vitamin C is a possible risk factor for knee OA, while certain food
groups, such as milk and dairy products, meat and poultry are beneficial for knee
OA [35]. Gut microbiome is highly molded by dietary nutrients as well [59, 60].
It is critical in the synthesis of vitamins and absorption and metabolism of otherwise
inaccessible nutrients. Vitamin D regulates calcium homeostasis in the intestine, kid-
ney and bone. It was shown that Vitamin D deficiency contributes to the pathogen-
esis of Crohn’s disease and non-alcoholic fatty liver disease (NAFLD) and its
supplementation has shown a positive effect in these patients and through regulating
microbiome [61]. Moreover, magnesium deficiency has been shown to adversely
affect gut microbial composition and to promote both anxiety and depressive-likeon.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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fat diet decreases the number of bacterial species in the gut microbiome. It was
shown, for example, that A. muciniphila decreases in obese animals and those
with type 2 diabetes. While, prebiotic feeding of A. muciniphila normalizes its quan-
tity and improves metabolic profiles [63]. Treatment with A. muciniphila also re-
duces inflammation, fat mass and insulin resistance induced by a high-fat diet
[63]. Moreover, a fiber-rich diet has been shown to be beneficial to health because
it modulates positively the gut microbiome [64]. A theory to explain nutrient-
induced changes of the gut microbiome is that dietary nutrients alter the microenvi-
ronment of gut microbiome in terms of its digestion capacity, structure and immu-
nological reactions of the host. These data suggest that nutrients affect host
physiological functions depending on the gut microbiome [65, 66]. Modifications
of nutrients intake, and thus of the gut microbiome microenvironment, may be an
interesting strategy to prevent OA [67]. However, this aspect needs to be substanti-
ated by additional studies.2.3. The impact of lifestyle on the gut microbiome
The potential impact of lifestyle factors on the gut microbiome has been largely dis-
regarded. Smoking habits, stress, travelling, poor healthy conditions and personal
hygiene, host interactions with environment, life sharing conditions, disruptions in
the circadian rhythm and lack of exercise can significantly impact the intestinal func-
tion and determine microbiome alterations [68]. Frantic life-style, consumption of
industrial foods, snacks, prevalence of a high fat/high sugar “Western diet” and
sedentary lifestyle are increasingly becoming predominant in daily life, resulting
in phenotypically and epigenetically obvious consequences [69] (Fig. 3). In recent
years, it has been shown that nutritional habits influence qualitatively and quantita-
tively our lives. A potentially harmful diet of nowadays, commonly known as
“Western diet” is primarily the result of a combination of additive and harmful in-
gredients, such as animal fats and glucose in excessive quantities and lack of nutri-
tional factors, such as vitamins and minerals, essential for our body. Moreover,
wrong habits (smoking, sedentary life, alcohol abuse) and unhealthy dietary habits
(fast and fatty food) may predispose people to obesity, and thus, to many other com-
plications which may lead to the development of severe metabolic dysfunctions [70].
It is also well known that sedentary behavior is associated with an increased risk of
developing several chronic diseases. In recent epidemiologic findings, it has been
indicated as an independent risk factor for both morbidity and mortality [71]. Inter-
estingly, smoking has a significant influence on gut microbiota composition. Indeed,
smoking as well as lack of physical activity, can significantly impact the large bowel
as are also considered risk factors for colorectal cancer [72]. Moreover, it has been
demonstrated that stress has an impact on colonic motor activity via the gut-brain
axis which can alter gut microbiota profiles [73]. Stress may contribute to functionalon.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Fig. 3. Proposed schematic representation of how the gut microbiome is regulated. Risk factors such as
alcohol consumption, tobacco, salt, sugar and fast food diet negatively influence the microbiome and the
immune system. Conversely, a diet rich in fibers, improves the gut microbiome and boosts the immune
system. This figure was drawn using the software CorelDraw and the vector image bank of Servier Med-
ical Art (http://smart.servier.com/). Servier Medical Art by Servier is licensed under a Creative Commons
Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
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crobial populations via the central nervous system. Finally, sedentary lifestyle and
excessive energy intake may lead to obesity. In fact, the lack of exercise influences
shifts in microbial populations that seem to find some associations with obesity. In
humans and animal models of obesity, shifts in gut microbiome composition could
potentially contribute to adiposity through greater energy harvest [74, 75]. On the
contrary, healthy lifestyle, based on a healthy diet, regular sleeping habits and phys-
ical activity helps to maintain the gut microbiome healthier [76]. It improves mental
health and general physical condition, including the hematopoietic system, bone,
cartilage and muscles, as well as the immune system and cardiovascular function
[77, 78] among a range of additional benefits [79, 80].2.4. Influence of physical activity and diet on the intestinal
microbiome
Exercise is considered as a metabolism modulator and the metabolic changes it in-
duces may be partially responsible for an improved health [81, 82] (Fig. 4). Nonethe-
less, the mechanisms by which exercise prevents disease occurrence and improveson.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Fig. 4. Regular moderate physical exercise plays a role in weight control, decreases the risk of diabetes
and regularizes the function of the gut microbiome. A correct physical exercise could exert positive ef-
fects on joints, muscles, bones and microbiome, consequently preventing osteoarthritis (OA) develop-
ment. On the other hand, excessive and incorrect physical exercise could be a risk factor for OA.
This figure was drawn using the software CorelDraw and the vector image bank of Servier Medical
Art (http://smart.servier.com/). Servier Medical Art by Servier is licensed under a Creative Commons
Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).
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of evidence suggests that gut microbiome can be implicated in this process. Several
studies in animal models and humans have found correlations between specific alter-
ations in the gut microbiome and physical activity. Studies on animal models
demonstrated that exercise could reverse unhealthy states, such as diet-induced
obesity, diabetes and endotoxin-induced toxicity, by shifting the a-diversity of gut
microbiome [83, 84, 85]. These finding have been confirmed by two studies on pro-
fessional athletes [86, 87]. Generally, the a-diversity of the gut microbiome refers to
a “healthier” intestinal microbiota that promotes gut health and maintains essential
structural, metabolic and signaling functions. In particular, in a recent study by
Zhao and coauthors [88], it has been demonstrated that physical activity based on
long-distance running, induced significant increase in the Coriobacteriaceae family,
whose activity has been reported to be involved in the metabolism of bile salts and
steroids as well as in the activation of dietary polyphenols in the human gut. In
particular, strong positive correlations between Coriobacteriaceae and the steroidon.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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found. The latter exerts many important functions, such as cell signaling, fuel and
energy storage, and membrane integrity/stability. Evidence in literature has also
shown that aldosterone levels in the plasma rise significantly in response to stress
caused by long-distance running [89]. Thus, the metabolism of Coriobacteriaceae
may be considered a potential factor contributing to explain the underlying the
role of exercise in preventing disease and improving health outcomes, further sug-
gesting the existence of a link between exercise, intestinal microbiota and health
improvement. There is some indication showing that regular physical activity is
also protective against developing chronic inflammatory diseases [90, 91, 92, 93].
Furthermore, exercise can determine changes in the gut microbial composition, play-
ing a positive role in energy homeostasis and regulation [94, 95]. Aerobic physical
activity modulates vagal tone, which is crucial in regulating the brain-gut micro-
biome axis. Exercise and the gut microbiome share several immunometabolic and
physiological activities that are well recognized in cardiovascular health and other
areas beyond the gut [96]. Conversely, additional investigations are essential to
ascertain the anti-inflammatory and metabolic consequences of moderate exercise
and the hypothetical threats of excessive exercise [97]. An intense physical activity
determines a pleiotropic effect in the entire body. The physiological processes of our
body undergo continuous adjustments and adaptations to the increased metabolic de-
mand caused by the intense physical effort. Electrolyte imbalance, regulation of
glycogen storage, increased oxidative stress, muscle damage, increased release of
endotoxins from gram negative bacteria and systemic immune activation, are all con-
ditions purportedly associated with intense physical activity and may determine al-
terations of intestinal permeability [98]. Adaptations to exercise might be influenced
by the gut microbiome, which shows a significant function in the production, stor-
age, and expenditure of energy obtained through the diet as well as in inflammation,
redox reactions, and hydration status [99]. During endurance exercise, transient
immunosuppression and inflammatory changes are observed, as well as the regula-
tion of lipid and carbohydrate metabolism, mitochondrial biogenesis, oxidative
stress, and dehydration [94, 100]. The gut microbiome ferments complex dietary
polysaccharides, which may be used as sources of energy in the liver and in muscle
cells to improve endurance performance, by maintaining glycaemia over time [101,
102]. Physical activity has been shown to control neutrophil function and migration,
decrease colonic mucosal permeability, inhibit inflammatory cytokines and control
the redox environment within the cell, which might help delaying fatigue symptoms
in endurance athletes [103]. Given that many endurance dietary plans are based on
high protein and carbohydrate levels, a key challenge is to design diets that limit the
microbial profiles able to produce toxic metabolites from protein degradation whilst
increasing the number of microorganisms that improve energy metabolism, thereby
reducing oxidative stress and systemic inflammation [104]. Currently, the main di-
etary intervention to modulate gut microbiome involves the supplementation ofon.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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strains might help maintaining a state of general health, enhance immune function,
improve gut mucosal permeability, reduce oxidative stress and improve our ability to
obtain energy from plant-carbohydrate sources [105, 106]. It is therefore important
for future research to dissect the respective influences that high intensity or moderate
exercise and the intestinal microbiome may have on the immune system, redox sys-
tem, and energy metabolism and to track the impact of functional foods on the intes-
tinal microbiome [106, 107].2.5. Gut microbiota manipulation by nutrition boosters
Reinstatement of a healthy gut microbiota is shown to have positive effects on the
treatment of dysbiosis-related diseases. The regulation of the intestinal microbiome
in healthy individuals may also be helpful in disease prevention. Therefore, manip-
ulation of the gut microbiome presents valuable avenues for therapeutic and clinical
applications. To positively influence health through therapeutic modulation of the
gut microbiome, the latter can be manipulated by changing the composition and/
or the functional output of metabolic products. In particular, the manipulation of
the gut microbiome can be reached by using targeted prebiotics, probiotics and en-
gineered probiotics. It is correct, at this point, to make a distinction between prebi-
otics (indigestible and non-absorbable substances) and probiotics (live organisms).
The current definition of prebiotics is proposed as “a substrate that is selectively uti-
lized by host microorganisms conferring a health benefit” [108]. With regards to pre-
biotics, their main function is to stimulate the activity and growth of bacteria in the
digestive tract. The main characteristics of these substances are the ability to resist to
the action of hydrolytic enzymes and to the low pH of the gastric enzymes. The gut
microbiome determines the fermentation of prebiotics and the consequent transfor-
mation into SCFAs that can be used as a source of energy [109]. During the fermen-
tation process, several metabolites are produced, many of which elicit a numberof
biological activities [110]. Prebiotics are mainly composed of fibers, present in a va-
riety of foods such as whole grain, fruit, root vegetables, and legumes. The inulin-
type fructans oligofructose, fructo-oligosaccharides and the galactan galacto-
oligosaccharide belong to the prebiotics groups. It has been shown that the fermen-
tation of prebiotics such as fructo-oligosaccharides can help in the prevention of dis-
eases such as osteoporosis, obesity, and colorectal cancer [94]. The consumption of
fermentable fibers or the combinations of prebiotics represent a good strategy to acti-
vate the gut microbes and improve health benefits [111, 112]. Many are the health
benefits provided by dietary fiber intake such as significantly lower risk for devel-
oping coronary heart disease, stroke, hypertension, diabetes, obesity and certain
gastrointestinal diseases. Increasing fiber intake also lowers blood pressure and
serum cholesterol levels, glycaemia and insulin sensitivity in non-diabetic and dia-
betic individuals. Fiber supplementation in obese patients significantly enhanceson.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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the gastrointestinal tract, including gastroesophageal reflux disease, duodenal ulcer,
diverticulitis, constipation, and hemorrhoids. Prebiotic fibers appear to enhance im-
mune function as well [113]. It has been shown that also the diet-mediated manip-
ulation of the gut microbiome confers health benefits to the host [114]. Within the
gastrointestinal tract, probiotics play a number of functional roles, including, regu-
lating mucin secretion, producing antimicrobial peptides, maintaining the intestinal
barrier integrity and influencing cytokines’ production [115]. Probiotics generally
promote gut health through different mechanisms, such as regulation of pH levels
and by affecting colonization resistance [114]. Currently, well-known gram-positive
bacteria that confer such health benefits include Bifidobacterium and Lactobacillus
[116]. Noteworthy are also the so called next-generation probiotics, referred to as a
new class of organisms for exclusive pharmaceutical application. The notion of
“new generation probiotics” comes from the increasing knowledge of the human mi-
crobiome, which individualizes the novel dominant members of the adult micro-
biota. In this sense, the literature highlights the interest towards several species
such as Faecalibacterium prausnitzii and Akkermansia muciniphila as potential
novel classes to be used for medical purposes [117]. Patients diagnosed with muscu-
loskeletal diseases are reported to have a predisposition for gastrointestinal distur-
bances that includes dyspepsia, nausea, abdominal bloating and irregular bowel
habits [118]. The intake of high-dose analgesic pharmaceuticals for musculoskeletal
pain [119] has adverse effects on gastrointestinal physiology and morphology further
inducing barrier integrity loss and inflammation [120]. The gut microbiome viability
and growth may potentially be disrupted with the use of these medications. Probiot-
ics and prebiotics may be endowed with therapeutic effects that can restore gastro-
intestinal barrier functionality and down regulate pro-inflammatory mediators by
modulating the activity of, for example, Clostridia species, known to induce the
release of pro-inflammatory mediators [121, 122]. Obesity-related OA is potentially
driven by a persistent low-grade inflammatory process partaken by dysbiosis of the
gut microbiome. Although further investigations are required, current evidence sug-
gests that the condition may be prevented/treated by restoring a healthy microbial
community certain prebiotics, includingthe indigestible prebiotic fiber oligofructose.
The latter might reduce systemic inflammation and, probably, contribute to preserve
articular cartilage damage and OA onset in obese people [8, 35].3. Conclusions
The intestinal microbiota is strictly associated with the pathogenesis of numerous
disorders. Interestingly, emerging evidence leads to the hypothesis that alterations
in the gut microbiome could also be considered as possible triggering factors in
the onset of musculoskeletal disorders such as OA. The most accredited linkingon.2019.e01134
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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Article Nowe01134factor between these two disorders may be represented by the common appearance
of a chronic low-grade inflammation, supporting a new OA phenotype, indicated as
the metabolic OA. As discussed in the present narrative review, OA and gut dysbio-
sis share numerous triggering risk factors such as aging, gender, obesity and nutri-
tion. Since the gut microbiome composition may be altered by several factors such as
sedentary life, use of medicines, smoking, stress, traveling, wrong dietary habits
(Western diet), life sharing conditions, etc, preservation of the health status of the
intestinal flora results of fundamental importance to prevent the onset of numerous
diseases. Manipulation of the intestinal microbiota, along with the associated posi-
tive outcomes, may be achieved by switching to an healthy lifestyle, based on reg-
ular physical activity, healthy diet enriched by vitamins, minerals and nutrition
boosters such as prebiotics and probiotics, and regular sleeping habits. In the future,
it is foreseeable that the gut microbiome profile may be use as a tool to predict per-
formance and detect potential disorders. Moreover, manipulation of the gut micro-
biome could be a potentially novel intervention to tackle or prevent metabolic
OA. However, this field needs to be further investigated.Declarations
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